Literature DB >> 2361917

Influence of passive changes of lung volume on upper airways.

F Sériès1, Y Cormier, M Desmeules.   

Abstract

The total upper airway resistances are modified during active changes in lung volume. We studied nine normal subjects to assess the influence of passive thoracopulmonary inflation and deflation on nasal and pharyngeal resistances. With the subjects lying in an iron lung, lung volumes were changed by application of an extrathoracic pressure (Pet) from 0 to 20 (+Pet) or -20 cmH2O (-Pet) in 5-cmH2O steps. Upper airway pressures were measured with two low-bias flow catheters, one at the tip of the epiglottis and the other in the posterior nasopharynx. Breath-by-breath resistance measurements were made at an inspiratory flow rate of 300 ml/s at each Pet step. Total upper airway, nasal, and pharyngeal resistances increased with +Pet [i.e., nasal resistance = 139.6 +/- 14.4% (SE) of base-line and pharyngeal resistances = 189.7 +/- 21.1% at 10 cmH2O of +Pet]. During -Pet there were no significant changes in nasal resistance, whereas pharyngeal resistance decreased significantly (pharyngeal resistance = 73.4 +/- 7.4% at -10 cmH2O). We conclude that upper airway resistance, particularly the pharyngeal resistance, is influenced by passive changes in lung volumes, especially pulmonary deflation.

Entities:  

Mesh:

Year:  1990        PMID: 2361917     DOI: 10.1152/jappl.1990.68.5.2159

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  32 in total

1.  Hypocapnia is associated with increased upper airway expiratory resistance during sleep.

Authors:  Abdul Ghani Sankri-Tarbichi; Nekeyua N Richardson; Susmita Chowdhuri; James A Rowley; M Safwan Badr
Journal:  Respir Physiol Neurobiol       Date:  2011-04-13       Impact factor: 1.931

Review 2.  Sleep. 2: pathophysiology of obstructive sleep apnoea/hypopnoea syndrome.

Authors:  R B Fogel; A Malhotra; D P White
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

Review 3.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

Review 4.  Pathophysiology of adult obstructive sleep apnea.

Authors:  Danny J Eckert; Atul Malhotra
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

5.  Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.

Authors:  Likurgos Kolilekas; Effrosyni Manali; Katerina A Vlami; Panagiotis Lyberopoulos; Christina Triantafillidou; Konstantinos Kagouridis; Katerina Baou; Sotirios Gyftopoulos; Konstantinos N Vougas; Anna Karakatsani; Manos Alchanatis; Spyros Papiris
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

6.  Lung volume and continuous positive airway pressure requirements in obstructive sleep apnea.

Authors:  Raphael C Heinzer; Michael L Stanchina; Atul Malhotra; Robert B Fogel; Sanjay R Patel; Amy S Jordan; Karen Schory; David P White
Journal:  Am J Respir Crit Care Med       Date:  2005-04-07       Impact factor: 21.405

7.  Effect of a high-flow open nasal cannula system on obstructive sleep apnea in children.

Authors:  Brian McGinley; Ann Halbower; Alan R Schwartz; Philip L Smith; Susheel P Patil; Hartmut Schneider
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

8.  Weight Loss and obstructive sleep apnea: what lies AHEAD?

Authors:  Devon A Dobrosielski; Susheel P Patil
Journal:  Sleep       Date:  2013-05-01       Impact factor: 5.849

Review 9.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

10.  The effect of gender on compensatory neuromuscular response to upper airway obstruction in normal subjects under midazolam general anesthesia.

Authors:  Takao Ayuse; Yuko Hoshino; Shinji Kurata; Terumi Ayuse; Hartmut Schneider; Jason P Kirkness; Susheel P Patil; Alan R Schwartz; Kumiko Oi
Journal:  Anesth Analg       Date:  2009-10       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.